GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Acorda Therapeutics, Inc. (ACOR) [hlAlert]

Rating:
Neutral ACOR

Acorda Therapeutics, Inc. (ACOR) rated Neutral by Merriman

Posted on: Monday,  Sep 28, 2009  8:25 AM ET by Merriman

Acorda Therapeutics, Inc.
(NASDAQ: ACOR) rated Neutral by Merriman.

Acorda Therapeutics is commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the central nervous system. Acorda currently markets Zanaflex Capsules for the management of spasticity. The Company's lead product candidate, Fampridine-SR, for the improvement of walking ability in persons with multiple sclerosis. It develops therapies that restore neurological function to people with spinal cord injury, multiple sclerosis and related conditions of the nervous system.

Merriman provides advanced tools for acquiring such information. These tools integrate a combination of cycles, geocosmic signatures and trend analysis patterns in assisting the serious investor in their interpretation of the various financial markets and the general economy. In today's fast paced and seemingly chaotic marketplace, you need the edge that only a broader analysis of human activity can provide.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/15/2009 8:25 AM Buy
None
25.32
as of 12/31/2009
1 Week down  -7.20 %
1 Month down  -0.45 %
3 Months down  -5.33 %
1 YTD down  -5.33 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/28/2009 8:25 AM Hold
None
23.60

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy